Jain Global’s Astrana Health ASTH Stock Holding History

Jain Global’s Portfolio ASTH Stock Details ASTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-17,900	Closed	-$507K	–	1577
2025 Q3	$507K	Buy	+17,900	New	+$485K	﹤0.01%	738

Other funds holding ASTH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

325 Capital New York $274M AUM 49.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Jain Global's ASTH Position: Q4 2025 in Review

Jain Global sold out of Astrana Health (ASTH) in Q4 2025, closing a stake of 17,900 shares — an estimated $507K sold.

Jain Global first reported a position in ASTH in Q3 2025 and held it in 1 quarter. The position peaked at $507K in Q3 2025. 175 funds tracked by Wall St. Rank hold ASTH as of Q4 2025.

Jain Global reported no remaining Astrana Health position as of Q4 2025 after selling out during the quarter.
Jain Global sold 17,900 Astrana Health shares in Q4 2025, an estimated $507K.
Jain Global first reported a position in Astrana Health in Q3 2025 and held it in 1 quarter.
Jain Global's Astrana Health position peaked at $507K in Q3 2025.
175 funds tracked by Wall St. Rank held Astrana Health as of Q4 2025.

Based on Jain Global's 13F filing for Q4 2025, filed 17 Feb 2026.